Edition:
India

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.91USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$2.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
346,296
52-wk High
$3.16
52-wk Low
$2.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 67.90 0.178
Jun '18 46.58 -0.764
Mar '18 38.52 0.010
FY 2017 Dec '17 68.04 0.151
Sep '17 62.75 0.136
Jun '17 143.84 0.386
Mar '17 45.44 0.044
FY 2016 Dec '16 66.49 -0.063
Sep '16 53.64 0.085
Jun '16 21.05 0.025
Mar '16 103.12 0.341
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 46.08 46.08 46.08 63.05
Quarter Ending Mar-19 1 35.35 35.35 35.35 --
Year Ending Dec-18 2 194.22 199.07 189.36 200.03
Year Ending Dec-19 2 122.96 126.86 119.05 143.10
Earnings (per share)
Quarter Ending Dec-18 1 0.08 0.08 0.08 0.14
Quarter Ending Mar-19 1 0.05 0.05 0.05 --
Year Ending Dec-18 2 -0.55 -0.50 -0.60 0.33
Year Ending Dec-19 2 0.14 0.15 0.13 0.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -58.62 -18.80 -7.57
EPS (TTM) % -80.96 -38.44 -6.64
Dividend % -83.33 -44.97 -30.12
Note: Units in Millions of US Dollars

Performance for PDL BioPharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.89 4.17 99 --
13 Week 43.70 36.70 99 --
26 Week 66.02 53.40 99 --
52 Week 5.23 -10.81 99 --
YTD 61.32 41.67 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 89.02%
# of Holders: 214
Total Shares Held: 129,949,725
3 Mo. Net Change: -43,023
# New Positions: 9
# Closed Positions: 22
# Increased Positions: 40
# Reduced Positions: 63
# Net Buyers: -23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.